B+ Good report. The company beat and showed some forward improvement, with a few meaningful caveats.

Guidance: The company reaffirmed full-year operating EBITDA guidance of $4 billion to $4.2 billion with earnings per share of $3.45 to $3.70. Management expects continued volume growth in crop protection in Latin America in the second half, with seed pricing expected to improve in the back half despite near-term commodity cost headwinds. The company is incorporating a $40 million headwind from higher oil prices.

Call summary: Corteva had a strong first quarter with organic sales up 7 percent, driven by seed volume growth of 6 percent and crop protection gains across all regions. Operating EBITDA jumped 21 percent year over year to over $1.4 billion, with margin expansion of 240 basis points coming from price gains, cost savings, and favorable currency effects. Management highlighted that net royalty expense fell another $30 million as the seed business moves toward royalty positive status later this year, particularly from licensing deals like Enlist soybeans in Brazil.

+ EPS beat estimates by 25.4%; Revenue beat estimates by 3.6%

B+ Good report. The company beat and showed some forward improvement, with a few meaningful caveats.

Guidance: Management expects full-year FFO between $1.71 and $1.75 per share, up from previous guidance, reflecting the successful Janus Living spin and senior housing outperformance. They plan to deploy about $750 million into acquisitions by year-end to offset IPO dilution and drive growth in 2027.

Call summary: Healthpeak had a solid first quarter with outpatient medical leasing spreads of 5.4 percent and occupancy at 91 percent, while life science occupancy reached 77.7 percent with strong leasing momentum. The company completed the Janus Living IPO generating value and deployed $714 million into senior housing acquisitions, plus bought back $100 million of stock in April to improve future earnings. Management noted that life science market conditions are improving with strong M&A activity and capital raising, and they expect occupancy to grow at least 100 basis points by year-end.

+ EPS beat estimates by 515.4%; Revenue beat estimates by 7.3%

B+ Good report. The company beat and showed some forward improvement, with a few meaningful caveats.

Guidance: Management did not provide formal earnings or revenue guidance. They stated they will prioritize profitability and shareholder returns over top line growth. For the April 1 renewal, property catastrophe rates fell 13 percent globally but terms and conditions held. For the June 1 Florida renewal, they expect rates to come down in the mid-teens range but maintained strong pricing discipline.

Call summary: Everest reported a strong first quarter with underwriting income of $316 million and net investment income of $567 million, producing operating earnings per share of $16.08. The treaty reinsurance segment delivered excellent results with an 87.2 percent combined ratio. The company completed a strategic pivot away from casualty reinsurance and U.S. retail insurance, reducing casualty premium by over $1.2 billion over two years while rotating toward short-tail and specialty lines. They raised the quarterly share repurchase floor to $300 million, reflecting confidence that the stock does not reflect the company's true value.

+ EPS beat estimates by 11.7%

B+ Good report. The company beat and showed some forward improvement, with a few meaningful caveats.

Guidance: American Express reaffirmed full year guidance of 9 to 10 percent revenue growth and earnings per share of $17.30 to $17.90, despite delivering 11 percent revenue growth in the first quarter. The company is reinvesting the outperformance in marketing and technology instead of raising guidance.

Call summary: American Express had a very strong first quarter with revenue growth of 11 percent and earnings per share of $4.28, up 18 percent year over year. Card member spending grew 10 percent, the highest quarterly growth in 3 years, driven by strength in travel and dining. The company is investing heavily in commercial products, artificial intelligence capabilities, and sports partnerships including a new multiyear agreement with the National Football League to become the league's official payments partner.

+ EPS beat estimates by 5.3%; Revenue beat estimates by 11.0%

B+ Good report. The company beat and showed some forward improvement, with a few meaningful caveats.

Guidance: CVS raised full year earnings guidance to $7.30 to $7.50 per share, up from $7.00 to $7.20. They expect at least $405 billion in revenue for the year. Operating cash flow guidance improved to at least $9.5 billion.

Call summary: CVS delivered a strong first quarter with $100.4 billion in revenue, up 6 percent year over year, and earnings per share of $2.57, beating consensus by 36 cents. The Aetna health insurance business showed major improvement with operating income up 1 billion dollars year over year and a better medical benefit ratio. Pharmacy sales grew 3 percent at existing stores driven by strong prescription volume increases. Management is focused on affordability, reducing friction in the health system, and launching a new consumer app called Health100 powered by artificial intelligence.

+ EPS beat estimates by 15.8%; Revenue beat estimates by 4.6%

B+ Good report. The company beat and showed some forward improvement, with a few meaningful caveats.

Guidance: Management raised their full year outlook for the Specialties business, now expecting between $1.3 billion and $1.5 billion in sales and $225 million to $275 million in adjusted earnings. They kept their Energy Storage outlook unchanged despite supply chain disruptions from the Middle East, estimating the cost impact at $70 million to $90 million. The company expects to offset these costs through lower interest expense from debt paydown and better than expected Specialties pricing and volumes.

Call summary: Albemarle had a strong first quarter with $1.43 billion in revenue, up 33 percent from last year, and $664 million in adjusted earnings, more than double the prior year. The company benefited from higher lithium prices (up 51 percent), increased volumes in Energy Storage of 14 percent, and successful cost cutting that saved $40 million so far this year. The company paid down $1.3 billion of debt, improving its financial flexibility, and generated $248 million in free cash flow in the quarter.

+ EPS beat estimates by 166.8%; Revenue beat estimates by 7.2%

B+ Good report. The company beat and showed some forward improvement, with a few meaningful caveats.

Guidance: Management guided Q2 revenue of $8.1 to $8.2 billion and adjusted EPS of $1.14 to $1.16, representing 43 to 45 percent sales growth and 41 to 43 percent EPS growth versus last year. They expect IT datacom to grow low teens sequentially as AI data center investments accelerate.

Call summary: Amphenol delivered record $7.6 billion revenue in Q1 2026, up 58 percent year over year with organic growth of 33 percent. IT datacom surged 81 percent organically driven by AI demand and now represents 41 percent of sales. The company booked record $9.4 billion in orders with a 1.24 to 1 book-to-bill ratio. Adjusted operating margins hit 27.3 percent despite CommScope acquisition being margin dilutive. Management is confident in long-term AI data center opportunity with broad product portfolio including copper, power and optical solutions.

+ EPS beat estimates by 11.3%; Revenue beat estimates by 6.5%

B+ Good report. The company beat and showed some forward improvement, with a few meaningful caveats.

Guidance: Baker Hughes reaffirmed its full year revenue and earnings targets. They expect about $6.5 billion in second quarter revenue and $1.13 billion in adjusted EBITDA. Management assumes the Middle East conflict continues through June, then gradually improves in the second half of the year.

Call summary: Baker Hughes delivered a strong first quarter with adjusted earnings per share of $0.58, beating expectations of $0.50. Energy infrastructure orders hit a record $4.9 billion, driven by data center power demand and liquefied natural gas projects. The Middle East conflict caused some disruption but strong performance elsewhere, particularly in power systems and gas compression, more than offset those challenges.

+ EPS beat estimates by 16.2%; Revenue beat estimates by 3.0%

B+ Good report. The company beat and showed some forward improvement, with a few meaningful caveats.

Guidance: CareDx expects about $456 million in revenue for 2026, up 20 percent from 2025. They also expect adjusted EBITDA of about $50 million, up 58 percent. The company is selling off its Lab Products business for $170 million in cash and acquiring Navaris, which makes cancer tests for about $34 million in revenue last year.

Call summary: The company reported strong first quarter results with $118 million in revenue, up 39 percent year over year, beating expectations by about $11 million. Testing services grew 48 percent and each test brought in $16.60 on average. Management announced two major moves: selling the Lab Products business to focus on testing services, and acquiring Navaris to expand into viral cancer testing where they can apply their expertise in repeat monitoring and workflow automation.

+ EPS beat estimates by 149.6%; Revenue beat estimates by 10.8%

B+ Good report. The company beat and showed some forward improvement, with a few meaningful caveats.

Guidance: Management provided no specific forward guidance for upcoming quarters or the full year. They reaffirmed their long-term combined ratio target of 92 to 98 percent but acknowledged that 2026 results could run below those targets due to market pricing pressure, particularly in commercial lines. They expect to continue disciplined risk selection and pricing policy by policy regardless of competitive headwinds.

Call summary: Cincinnati Financial reported first quarter net income of $274 million, with excellent operational results despite investment portfolio losses. The property casualty combined ratio improved sharply to 95.6 percent, and the accident year ratio before catastrophe losses hit 87.5 percent, showing strong underwriting discipline. Net written premiums grew 7 percent, but growth is moderating as the hard insurance market softens and larger commercial accounts face increased pricing pressure from competitors.

+ EPS beat estimates by 5.7%

B+ Good report. The company beat and showed some forward improvement, with a few meaningful caveats.

Guidance: DaVita raised its full year adjusted earnings per share guidance to a range of $14.10 to $15.20, up from prior expectations. The company also raised treatment volume guidance to grow 25 to 50 basis points for the full year, driven by better underlying mortality, productivity gains, and patient transfers from Fresenius clinic closures.

Call summary: DaVita delivered strong first quarter results with adjusted earnings per share of $2.87, beating consensus of $2.41. Treatment volume came in slightly ahead of plan, revenue per treatment grew 4 percent year over year, and labor productivity improved. The company is making significant investments in AI and digital infrastructure, including tools like ScheduleHub for dynamic clinic scheduling, and expects these technology investments to drive long-term clinical and operational improvements.

+ EPS beat estimates by 22.6%

B+ Good report. The company beat and showed some forward improvement, with a few meaningful caveats.

Guidance: Air Products kept its full-year profit guidance at $12.85 to $13.15 per share, expecting 7 to 9 percent growth. For the next quarter, they said earnings would be $2.95 to $3.10 per share, about 10 to 15 percent higher than last year. The company faces helium weakness but sees pricing gains offsetting that.

Call summary: The quarter delivered strong underlying results with adjusted operating income up 12 percent and margins expanding to 24.4 percent despite sluggish economic conditions. Pricing actions and productivity drove gains across segments, though helium sales fell about 4 percent for the year due to tough prior-year comparisons. Management remains focused on disciplined capital spending, the Darrow ammonia project negotiations with Yara, and bringing new assets online in electronics and aerospace sectors.

+ EPS beat estimates by 3.4%; Revenue beat estimates by 2.4%

B+ Good report. The company beat and showed some forward improvement, with a few meaningful caveats.

Guidance: The company reaffirmed its full year earnings guidance of $11 to $12 per share. Management highlighted free cash flow of $8.4 billion across 2026 and 2027, with further growth to $11.5 billion to $13 billion in 2028 and 2029 before optional upside levers.

Call summary: Constellation delivered a strong first quarter, earning $2.74 per share in adjusted operating earnings, mostly from Calpine accretion and higher capacity prices in PJM. The company also repurchased $335 million of stock at an average price of $285 per share. Management emphasized that regulatory clarity in PJM on large data center connections is expected by year end, which should unlock substantial customer contracting that has been paused pending those rules.

+ EPS beat estimates by 5.7%; Revenue beat estimates by 26.3%

B+ Good report. The company beat and showed some forward improvement, with a few meaningful caveats.

Guidance: Dominion reaffirmed its full year earnings guidance of 5 to 7 percent growth with a bias toward the upper half starting in 2028. The company did not provide specific revenue or earnings targets for coming quarters but said it remains on track with its capital plan and financial commitments.

Call summary: First quarter operating earnings came in at 0.95 per share, beating expectations of 0.89. The Coastal Virginia Offshore Wind project is 75 percent complete and achieved first power to customers in March. The company has 10.4 gigawatts of data center capacity contracted and continues to see strong demand in Virginia. New Virginia legislation expanding energy storage requirements could open up 20 additional gigawatts of opportunity, which management will reflect in capital planning next year.

+ EPS beat estimates by 2.3%; Revenue beat estimates by 11.8%

B+ Good report. The company beat and showed some forward improvement, with a few meaningful caveats.

Guidance: Allot reaffirmed its full-year revenue guidance of $113 million to $117 million, but expressed increased confidence toward the upper end. The company now projects Security-as-a-Service revenue will grow 40 percent or more in 2026, up from previous guidance of robust double-digit growth. Management expects profitability and operating leverage to continue improving throughout the year.

Call summary: Allot delivered $26.4 million in revenue, up 14 percent year over year, with Security-as-a-Service revenue jumping 71 percent to $8.7 million and now representing one-third of total sales. The company generated record operating cash flow of $10.6 million, driven by strong profitability, project milestone payments from large Smart deals, and a healthy balance sheet with nearly $100 million in cash and no debt. Management highlighted strong customer adoption of cybersecurity services, a growing pipeline across all regions, and successful executions of multimillion-dollar Smart platform upgrades with tier-one operators.

+ EPS beat estimates by 35.7%

B+ Good report. The company beat and showed some forward improvement, with a few meaningful caveats.

Guidance: Boeing expects to deliver 500 737s and 90 to 100 787s in 2026. The company guides for 1 billion to 3 billion dollars in free cash flow for the year. Production rates will increase to 47 per month on the 737 this summer and to 10 per month on the 787 later in the year.

Call summary: Boeing had a strong start to 2026 with 22.2 billion dollars in revenue, up 14 percent. The 737 program delivered 114 aircraft and stabilized at 42 per month after fixing wiring issues on 25 planes. The 787 was held back by seat certification delays but remains on track. Defense revenue grew 21 percent to 7.6 billion dollars, driven by higher demand from military conflicts. Free cash flow usage of 1.5 billion in the quarter was better than expected due to recovery and good timing.

+ EPS beat estimates by 76.7%

B+ Good report. The company beat and showed some forward improvement, with a few meaningful caveats.

Guidance: CSX raised full year revenue guidance to mid-single-digit growth from low single digits, driven mainly by higher fuel prices starting in the second quarter. The company expects operating margin to expand 200 to 300 basis points, now trending toward the high end. Free cash flow should grow more than 60 percent versus 2025.

Call summary: CSX had a strong first quarter with revenue up 2 percent and costs down 6 percent, driving 26 percent EPS growth to 43 cents. Management highlighted over 100 productivity initiatives underway, cutting 7 percent off the vehicle fleet, improving fuel efficiency to a record 0.97 gallons per thousand ton miles, and launching new services. The Howard Street Tunnel bridge completion in the next week will unlock double-stack rail capacity for the East-West corridor and add new market connections.

+ EPS beat estimates by 9.2%

B+ Good report. The company beat and showed some forward improvement, with a few meaningful caveats.

Guidance: Dow guided second quarter revenue of approximately $12 billion and EBITDA of about $2 billion. Management expects pricing gains across all business segments to drive earnings higher, especially in polyethylene where April prices were announced up $0.30 per pound, with May prices rising another $0.20.

Call summary: Dow reported first quarter revenue of $9.8 billion and EBITDA of $873 million. The Middle East conflict disrupted global supply chains starting in March, creating tight conditions that benefited Dow's Americas-based assets. Management expects these supply constraints and pricing momentum to persist through 2026, delivering significant earnings upside in coming quarters as they execute cost-reduction and transformation initiatives.

+ EPS beat estimates by 51.8%